Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 498.79 million compared to CNY 414.41 million a year ago. Net income was CNY 79.45 million compared to CNY 45.26 million a year ago.

Basic earnings per share from continuing operations was CNY 0.21 compared to CNY 0.14 a year ago. Diluted earnings per share from continuing operations was CNY 0.21 compared to CNY 0.14 a year ago.